Breaking News
One of the rarest dimes in the U.S. sells for $1.25 million
US Cities Are Terminating Flock Camera Contracts at Record Pace After Nationwide Pushback
Data Center Leak in Oklahoma Releases Three Million Gallons Amid Severe Drought
Trump Admin Cyber Push Reaches Texas Water Systems, With Plans to Expand Nationwide
Top Tech News
It charges more than it discharges while driving
Dataminr AI tech to go live on NATO Maven system: CEO
The Most Dangerous Interview Ever Recorded? PART 2
2026 cars: George Orwell edition
Forgotten Amish Survival Bar: 500 Calories, No Fridge, 1930s Recipe
Your government bought military-grade spyware and it can hear you breathing, watch your camera...
Here's What to Expect as Air Taxis Actually Begin to Take Off
'Wood Foam' Startup Uses Logging Waste as Substitute for Plastic, Producing 400 Pounds Daily
How a Group of Young Men in 1933 Solved a Water Crisis in The Desert -- And Nobody Knows About It
Tesla's Cybercab Launch Is Next Week. Here's What Tesla Still Needs To Prove
AstraZeneca Coronavirus Vaccine to Be Pulled Worldwide for 'Commercial' Reasons
The Oxford-AstraZeneca coronavirus vaccine will be withdrawn worldwide just months after the firm admitted that the jab causes a rare but dangerous side effect, however, AstraZeneca insists that the decision to pull the vaccine was purely made for commercial reasons.
AstraZeneca pulled its "marketing authorisation" for its COVID-19 vaccine, known commercially as Vaxzevria, in the European Union on Tuesday and plans to do so in the UK and other countries where it was deployed in the coming months. The decision will not impact the United States, where the jab never received approval to go to market.
The pharmaceutical giant insisted that the decision was made for commercial considerations, saying that the vaccine is no longer being manufactured and that more recent vaccines have been developed to confront novel variants of the Chinese virus.